Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.15)
# 3,498
Out of 4,735 analysts
24
Total ratings
28.57%
Success rate
-3.01%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNS Marinus Pharmaceuticals | Downgrades: Neutral | n/a | $0.54 | - | 2 | Aug 14, 2024 | |
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $18.41 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $14.70 | +367.69% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $0.70 | +902.58% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $1.07 | +1,301.87% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $60 | $1.18 | +4,984.75% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $57.52 | -39.15% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $1.10 | +4,445.45% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $130 → $80 | $0.76 | +10,371.20% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $8.81 | +1,091.83% | 2 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $29 | $37.16 | -21.96% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $2.80 | - | 1 | Sep 27, 2017 |
Marinus Pharmaceuticals
Aug 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.54
Upside: -
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $18.41
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $14.70
Upside: +367.69%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $0.70
Upside: +902.58%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.07
Upside: +1,301.87%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $60
Current: $1.18
Upside: +4,984.75%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $57.52
Upside: -39.15%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $1.10
Upside: +4,445.45%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130 → $80
Current: $0.76
Upside: +10,371.20%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.81
Upside: +1,091.83%
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $37.16
Upside: -21.96%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $2.80
Upside: -